Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Multi Cap Fund median (32 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 21 Jun 2024 – 20 Aug 2026, limited by Motilal Oswal Multi Cap Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Motilal Oswal Multi Cap Fund | Nifty 500 |
|---|---|---|
| 21 Jun 2024 | ₹100.00 | ₹100.00 |
| 26 Aug 2024 | ₹114.06 | ₹105.96 |
| 31 Oct 2024 | ₹118.70 | ₹102.04 |
| 05 Jan 2025 | ₹136.10 | ₹102.12 |
| 11 Mar 2025 | ₹117.54 | ₹91.30 |
| 16 May 2025 | ₹130.03 | ₹102.85 |
| 21 Jul 2025 | ₹137.85 | ₹105.14 |
| 25 Sep 2025 | ₹134.84 | ₹103.54 |
| 30 Nov 2025 | ₹138.19 | ₹107.63 |
| 04 Feb 2026 | ₹125.78 | ₹105.84 |
| 10 Apr 2026 | ₹117.16 | ₹100.50 |
| 15 Jun 2026 | ₹130.09 | ₹102.95 |
| 20 Aug 2026 | ₹149.87 | ₹105.74 |
| Metric | Motilal Oswal · Direct NAV ₹15.36 Very High risk ★★★☆☆ 1Y | Category median Multi Cap Fund · 32 funds |
|---|---|---|
| +12.02% | +9.70% | |
| — | +16.81% | |
| — | +15.89% | |
| — | +15.33% | |
| +20.57% | +16.56% | |
| +17.22% | — | |
| — | +18.65% | |
| — | +16.76% | |
| — | +16.70% | |
| Risk | ||
| 18.47% | 14.82% | |
| 0.30 | 0.64 | |
| 0.43 | 0.87 | |
| -24.13% | -20.01% | |
| Nifty 500 | — | |
| — | +4.32% | |
| — | 1.01 | |
| — | 111.5% | |
| — | 92.7% | |
| 1.22% | 0.94% | |
| ₹4,007Cr | ₹3,392Cr | |
| 1.00% | — | |
| None | — | |
| ₹500 | — | |
| ₹500 | — | |
| 188% | 57% | |
| Rakesh Shetty | — | |
| 21 Jun 2024 | — | |
| 38 | — | |
| 40.4% | — | |
| 1.9% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.